<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092023000200088</article-id>
<article-id pub-id-type="doi">10.35366/110442</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Precisión diagnóstica de la nueva definición propuesta de lesión renal aguda (KDIGO más uNGAL) en pacientes críticamente enfermos]]></article-title>
<article-title xml:lang="en"><![CDATA[Diagnostic accuracy of the proposed new definition of acute kidney injury (KDIGO plus uNGAL) in critically ill patients]]></article-title>
<article-title xml:lang="pt"><![CDATA[Precisão diagnóstica da nova definição proposta de lesão renal aguda (KDIGO mais uNGAL) em pacientes em estado crítico]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jacinto Flores]]></surname>
<given-names><![CDATA[Sarahi Anilú]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alcántara Melendres]]></surname>
<given-names><![CDATA[Cynthia Ixchel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mora Martínez]]></surname>
<given-names><![CDATA[Gabriela María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Visoso Palacios]]></surname>
<given-names><![CDATA[Porfirio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Esparza Correa]]></surname>
<given-names><![CDATA[Josué Gerardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Petróleos Mexicanos Hospital Central Sur de Alta Especialidad ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<volume>37</volume>
<numero>2</numero>
<fpage>88</fpage>
<lpage>94</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092023000200088&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092023000200088&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092023000200088&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  lo que ahora conocemos como lesión renal aguda (LRA) en el siglo pasado tuvo al menos 25 conceptos y 35 definiciones diferentes; en este siglo se desarrollaron las definiciones y sistemas de clasificación por gravedad, risk of renal dysfunction, injury to the kidney, failure of kidney function, loss of kidney function, end-stage kidney disease (RIFLE por sus siglas en inglés), AKIN, Kidney Disease: Improving Global Outcome (KDIGO) basadas en creatinina, gasto urinario y necesidad de terapia de reemplazo renal. En la última década se han estudiado biomarcadores de LRA. Se sugiere que se realice investigación sobre si una combinación de biomarcadores de daño y funcionales junto con información clínica en pacientes de alto riesgo podría ayudar a mejorar la precisión diagnóstica de nueva definición propuesta de LRA.  Objetivo:  estimar la precisión diagnóstica de la nueva definición propuesta de LRA en pacientes críticamente enfermos.  Material y métodos:  se realizó un estudio observacional, analítico, prospectivo y longitudinal en pacientes mayores de 18 años, ingresados a terapia intensiva del Hospital Central Sur de Alta Especialidad en el periodo comprendido del 01 de mayo de 2022 al 10 de julio de 2022.  Resultados:  en el grupo de estudio (41 pacientes) la media de la edad fue 62.5 ± 14.22 años; y 33 (80.5%) fueron hombres. La media del peso, talla e índice de masa corporal (IMC) fue de 78.5 ± 18.61, 1.65 ± 0.08 y 28.93 ± 6.72 kg/m2, respectivamente; 14 (34.1%) pacientes presentaron sobrepeso y 16 (39%) tuvieron obesidad; 29 (70.7%) tuvieron sepsis. En 24 (58.5%) pacientes, el foco de infección fue pulmonar, tres (7.3%) abdominal y dos (4.9%) vías urinarias. De los pacientes, 33 (80.5%) se clasificaron como 1S y 1B. El uNGAL al ingreso tuvo una media de 451.36 ± 688.11. La sensibilidad de KDIGO más uNGAL fue 67%, especificidad 16%. La sensibilidad de KDIGO más uNGAL fue 75%, especificidad 19%. La sensibilidad de KDIGO más uNGAL fue 88%, especificidad 25%. El porcentaje de mortalidad predicha por la escala SAPS 3 fue 56.26 ± 23.7% y de la escala MPM III 43.94 ± 23.59. La mortalidad observada fue de 24 (58.5%); y el índice estandarizado de mortalidad con SAPS 3 fue de 1.04, y con el MPM III fue de 1.33.  Conclusiones:  el rendimiento diagnóstico de la nueva definición de lesión renal aguda propuesta no fue bueno debido a múltiples factores, dentro de los dos más importantes, el manejo preventivo de la lesión renal aguda que actualmente se aporta a los pacientes y el tamaño de la muestra. Se requiere continuar el estudio para lograr la muestra representativa de la población y tener una conclusión certera sobre el rendimiento diagnóstico de la nueva definición propuesta de lesión renal aguda.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  what we now know as acute kidney injury (AKI) in the last century had at least 25 concepts and 35 different definitions; In this century, the RIFLE, AKIN, and KDIGO definitions and classification systems for severity were developed, based on creatinine, urine output, and need for renal replacement therapy. In the last decade, biomarkers of AKI have been studied; It is suggested that research be carried out on whether a combination of damage and functional biomarkers together with clinical information, in high-risk patients, could help improve the diagnostic accuracy of the proposed new definition of AKI.  Objective:  to estimate the diagnostic accuracy of the proposed new definition of AKI in critically ill patients.  Material and methods:  an observational, analytical, prospective and longitudinal study was carried out in patients older than 18 years, admitted to intensive care at the Hospital Central Sur de Alta Especialidad in the period from May 1, 2022 to July 10 2022.  Results:  in the study group (41 patients), the mean age was 62.5 ± 14.22 years; and 33 (80.5%) were men. The mean weight, height and body mass index (BMI) were 78.5 ± 18.61, 1.65 ± 0.08 and 28.93 ± 6.72 kg/m2, respectively; 14 (34.1%) patients were overweight and 16 (39%) patients were obese; 29 (70.7%) had sepsis. In 24 (58.5%) patients, the source of infection was pulmonary, 3 (7.3%) abdominal, and 2 (4.9%) urinary tract. Of the patients, 33 (80.5%) are classified as 1S and 1B. The uNGAL at admission had a mean of 451.36 ± 688.11. The sensitivity of KDIGO plus uNGAL was 67%, specificity 16%. The sensitivity of KDIGO plus NGAL was 75%, specificity 19%. The sensitivity of KDIGO plus uNGAL was 88%, specificity 25%. The percentage of mortality predicted by the SAPS 3 scale was 56.26 ± 23.7% and by the MPM III scale 43.94 ± 23.59. the observed mortality was 24 (58.5%); and the standardized mortality rate with SAPS 3 was 1.04, and with MPM III 1.33.  Conclusions:  the diagnostic performance of the new definition of acute kidney injury proposed was not good due to multiple factors, among the 2 most important, the preventive management of acute kidney injury that is currently provided to patients and the size of the sample. It is necessary to continue the study to achieve a representative sample of the population and to have an accurate conclusion about the diagnostic performance of the new proposed definition of acute kidney injury.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  o que hoje conhecemos como lesão renal aguda (LRA) teve no século passado pelo menos 25 conceitos e 35 definições diferentes; neste século, foram desenvolvidas as definições e sistemas de classificação de gravidade RIFLE, AKIN, KDIGO, baseados na creatinina, débito urinário e necessidade de terapia renal substitutiva. Na última década, foram estudadosos biomarcadores LRA; sugere-se que sejam realizadas pesquisas sobre se uma combinação de biomarcadores DE danos e funcionais juntamente com informação clínica, em pacientes de alto risco, poderia ajudar a melhorar a precisão diagnóstica da nova definição proposta de LRA.  Objetivo:  estimar a precisão diagnóstica da nova definição proposta de LRA em pacientes críticos.  Material e métodos:  foi realizado um estudo observacional, analítico, prospectivo e longitudinal em pacientes maiores de 18 anos internados na terapia intensiva do Hospital Central Sur de Alta Especialidad no período de 1o de maio de 2022 a 10 de julho de 2022.  Resultados:  no grupo de estudo (41 pacientes), a média de idade foi de 62.5 ± 14.22 anos; e 33 (80.5%) eram homens. As médias de peso, estatura e índice de massa corporal (IMC) foram 78.5 ± 18.61, 1.65 ± 0.08 e 28.93 ± 6.72 kg/m2, respectivamente; 14 (34.1%) pacientes apresentavam sobrepeso e 16 (39%) pacientes eram obesos; 29 (70.7%) tiveram sepse. Em 24 (58.5%) pacientes, o foco de infecção foi pulmonar, 3 (7.3%) abdominal e 2 (4.9%) trato urinário. Dos pacientes, 33 (80.5%) foram classificados como 1S e 1B. O uNGAL na admissão teve média de 451.36 ± 688.11. A sensibilidade de KDIGO mais uNGAL foi de 67%, especificidade de 16%. A sensibilidade de KDIGO mais NGAL foi de 75%, especificidade de 19%. A sensibilidade de KDIGO mais uNGAL foi de 88%, especificidade de 25%. O percentual de mortalidade previsto pela escala SAPS 3 foi de 56.26 ± 23.7% e pela escala MPM III 43.94 ± 23.59. a mortalidade observada foi de 24 (58.5%); e a taxa de mortalidade padronizada com SAPS 3 foi de 1.04 e com MPM III de 1.33.  Conclusões:  o desempenho diagnóstico da nova definição de lesão renal aguda proposta não foi bom devido a múltiplos fatores, entre os 2 mais importantes sendo o manejo preventivo da lesão renal aguda atualmente fornecido aos pacientes e o tamanho da amostra. É necessário continuar o estudo para obter uma amostra representativa da população e ter uma conclusão precisa sobre o desempenho diagnóstico da nova definição proposta de lesão renal aguda.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[lesión renal aguda]]></kwd>
<kwd lng="es"><![CDATA[uNGAL]]></kwd>
<kwd lng="es"><![CDATA[KDIGO]]></kwd>
<kwd lng="es"><![CDATA[RIFLE]]></kwd>
<kwd lng="es"><![CDATA[AKIN]]></kwd>
<kwd lng="es"><![CDATA[biomarcador]]></kwd>
<kwd lng="en"><![CDATA[acute kidney injury]]></kwd>
<kwd lng="en"><![CDATA[uNGAL]]></kwd>
<kwd lng="en"><![CDATA[KDIGO]]></kwd>
<kwd lng="en"><![CDATA[RIFLE]]></kwd>
<kwd lng="en"><![CDATA[AKIN]]></kwd>
<kwd lng="en"><![CDATA[biomarker]]></kwd>
<kwd lng="pt"><![CDATA[lesão renal aguda]]></kwd>
<kwd lng="pt"><![CDATA[uNGAL]]></kwd>
<kwd lng="pt"><![CDATA[KDIGO]]></kwd>
<kwd lng="pt"><![CDATA[RIFLE]]></kwd>
<kwd lng="pt"><![CDATA[AKIN]]></kwd>
<kwd lng="pt"><![CDATA[biomarcador]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Novis]]></surname>
<given-names><![CDATA[BK]]></given-names>
</name>
<name>
<surname><![CDATA[Roizen]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Aronson]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Thisted]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of preoperative risk factors with postoperative acute renal failure]]></article-title>
<source><![CDATA[Anesth Analg]]></source>
<year>1994</year>
<volume>78</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>143-9</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bellomo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ronco]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute renal failure: time for consensus]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2001</year>
<volume>27</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1685-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Chertow]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute renal failure definitions and classification: time for change?]]></article-title>
<source><![CDATA[J Am Soc Nephrol]]></source>
<year>2003</year>
<volume>14</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>2178-87</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Srisawat]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hoste]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Modern classification of acute kidney injury]]></article-title>
<source><![CDATA[Blood Purif]]></source>
<year>2010</year>
<volume>29</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>300-7</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prendergast]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The background of Galen&#8217;s life and activities, and its influence on his achievements]]></article-title>
<source><![CDATA[Proc R Soc Med]]></source>
<year>1930</year>
<volume>23</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1131-48</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eknoyan]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The origins of nephrology--Galen, the founding father of experimental renal physiology]]></article-title>
<source><![CDATA[Am J Nephrol]]></source>
<year>1989</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>66-82</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eknoyan]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Emergence of the concept of acute renal failure]]></article-title>
<source><![CDATA[Am J Nephrol]]></source>
<year>2002</year>
<volume>22</volume>
<numero>2-3</numero>
<issue>2-3</issue>
<page-range>225-30</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abercrombie]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Observations on Ischuria renalis]]></article-title>
<source><![CDATA[Edinb Med Surg J]]></source>
<year>1821</year>
<volume>17</volume>
<numero>67</numero>
<issue>67</issue>
<page-range>210-22</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cameron]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bright&#8217;s disease today: the pathogenesis and treatment of glomerulonephritis--I]]></article-title>
<source><![CDATA[Br Med J]]></source>
<year>1972</year>
<volume>4</volume>
<numero>5832</numero>
<issue>5832</issue>
<page-range>87-90</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dunn]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[McNeee]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A contribution to the study of war nephritis]]></article-title>
<source><![CDATA[Br Med J]]></source>
<year>1917</year>
<volume>2</volume>
<numero>2971</numero>
<issue>2971</issue>
<page-range>745-51</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franklin]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute renal failure related to traumatic injuries]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[HW]]></given-names>
</name>
</person-group>
<source><![CDATA[The Kidney: structure and function in health and disease]]></source>
<year>1951</year>
<page-range>752-813</page-range><publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Oxford Univ. Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Angus]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Palevsky]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ronco]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The first international consensus conference on continuous renal replacement therapy]]></article-title>
<collab>ADQI Workgroup</collab>
<source><![CDATA[Kidney Int]]></source>
<year>2002</year>
<volume>62</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1855-63</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bellomo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Palevsky]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Ronco]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute Dialysis Quality Initiative II: the Vicenza conference]]></article-title>
<source><![CDATA[Curr Opin Crit Care]]></source>
<year>2002</year>
<volume>8</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>505-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bellomo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ronco]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Palevsky]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2004</year>
<volume>8</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>R204-12</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[SV]]></given-names>
</name>
<name>
<surname><![CDATA[Molitoris]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Ronco]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Warnock]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Levin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2007</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>31</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<collab>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group</collab>
<article-title xml:lang=""><![CDATA[KDIGO Clinical Practice Guideline for Acute Kidney Injury]]></article-title>
<source><![CDATA[Kidney inter., Suppl]]></source>
<year>2012</year>
<volume>2</volume>
<page-range>1-138</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fujii]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Uchino]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Takinami]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bellomo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of the Kidney Disease Improving Global Outcomes criteria for AKI and comparison of three criteria in hospitalized patients]]></article-title>
<source><![CDATA[Clin J Am Soc Nephrol]]></source>
<year>2014</year>
<volume>9</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>848-54</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Luo]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Du]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Wen]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Xi]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute Kidney Injury Trial (BAKIT) workgroup. A comparison of different diagnostic criteria of acute kidney injury in critically ill patients]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2014</year>
<volume>18</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>144</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[TY]]></given-names>
</name>
<name>
<surname><![CDATA[Chien]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[FC]]></given-names>
</name>
<name>
<surname><![CDATA[Pan]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[SY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of RIFLE, AKIN, and KDIGO classifications for assessing prognosis of patients on extracorporeal membrane oxygenation]]></article-title>
<source><![CDATA[J Formos Med Assoc]]></source>
<year>2017</year>
<volume>116</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>844-51</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koeze]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Keus]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Dieperink]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[van der Horst]]></surname>
<given-names><![CDATA[IC]]></given-names>
</name>
<name>
<surname><![CDATA[Zijlstra]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[van Meurs]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria]]></article-title>
<source><![CDATA[BMC Nephrol]]></source>
<year>2017</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>70</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huber]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Schneider]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lahmer]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Küchle]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Jungwirth]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Schmid]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of RIFLE, AKIN, and a modified AKIN definition (&#8220;backward classification&#8221;) of acute kidney injury in a general ICU: analysis of a 1-year period]]></article-title>
<source><![CDATA[Medicine (Baltimore)]]></source>
<year>2018</year>
<volume>97</volume>
<numero>38</numero>
<issue>38</issue>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ratanarat]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Skulratanasak]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Tangkawattanakul]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hantaweepant]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for predicting hospital mortality in critically ill patients with multi-organ dysfunction syndrome]]></article-title>
<source><![CDATA[J Med Assoc Thai]]></source>
<year>2013</year>
<volume>96</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>224-31</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lopes]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandes]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Jorge]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Goncalves]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Costa e Silva]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute kidney injury in intensive care unit patients: a comparison between the RIFLE and the Acute Kidney Injury Network classifications]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2008</year>
<volume>12</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>110</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Levi]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[de Souza]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[de Magalhaes]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[de Carvalho]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Cunha]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Dantas]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of the RIFLE, AKIN and KDIGO criteria to predict mortality in critically ill patients]]></article-title>
<source><![CDATA[Rev Bras Ter Intensiva]]></source>
<year>2013</year>
<volume>25</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>290-6</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoste]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence, classification, and outcomes of acute kidney injury]]></article-title>
<source><![CDATA[Contrib Nephrol]]></source>
<year>2007</year>
<volume>156</volume>
<page-range>32-8</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ricci]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ronco]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The RIFLE criteria and mortality in acute kidney injury: a systematic review]]></article-title>
<source><![CDATA[Kidney Int]]></source>
<year>2008</year>
<volume>73</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>538-46</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Strimbu]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Tavel]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[What are biomarkers?]]></article-title>
<source><![CDATA[Curr Opin HIV AIDS]]></source>
<year>2010</year>
<volume>5</volume>
<page-range>463-6</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vanderlinde]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urinary enzyme measurements in the diagnosis of renal disorders]]></article-title>
<source><![CDATA[Ann Clin Lab Sci]]></source>
<year>1981</year>
<volume>11</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>189-201</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Piper]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kidd]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A new diagnostic immunoassay for proximal tubule injury]]></article-title>
<source><![CDATA[Toxicol Pathol]]></source>
<year>1986</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>232-7</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tolkoff-Rubin]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Piper]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hansen]]></surname>
<given-names><![CDATA[WP]]></given-names>
</name>
<name>
<surname><![CDATA[Bander]]></surname>
<given-names><![CDATA[NH]]></given-names>
</name>
<name>
<surname><![CDATA[Cordon-Cardo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis of renal proximal tubular injury by urinary immunoassay for a proximal tubular antigen, the adenosine deaminase binding protein]]></article-title>
<source><![CDATA[Nephrol Dial Transplant]]></source>
<year>1987</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>143-8</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Taira]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Yoshimura]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ideura]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Koshikawa]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical significance of urinary epidermal growth factor levels in patients with acute renal failure]]></article-title>
<source><![CDATA[Nephron]]></source>
<year>1992</year>
<volume>60</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>375</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Taira]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Yoshimura]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Iizuka]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Inui]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Oshiden]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Iwasaki]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Expression of epidermal growth factor and its receptor in rabbits with ischaemic acute renal failure]]></article-title>
<source><![CDATA[Virchows Arch]]></source>
<year>1996</year>
<volume>427</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>583-8</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peco-Anti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nasti-Miri]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Popovi-Rolovi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Adanja]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kosti]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Paripovi]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endothelin-1 in acute renal failure]]></article-title>
<source><![CDATA[Ren Fail]]></source>
<year>1996</year>
<volume>18</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>553-6</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bonventre]]></surname>
<given-names><![CDATA[JV]]></given-names>
</name>
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adhesion molecules and acute renal failure]]></article-title>
<source><![CDATA[Adv Nephrol Necker Hosp]]></source>
<year>1996</year>
<volume>25</volume>
<page-range>159-76</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yamada]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hishida]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kato]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Yoneyama]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[1,5-anhydroglucitol as a marker for the differential diagnosis of acute and chronic renal failure]]></article-title>
<source><![CDATA[Nephron]]></source>
<year>1996</year>
<volume>73</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>707-9</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rabb]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of urinary markers in acute renal failure]]></article-title>
<source><![CDATA[Curr Opin Nephrol Hypertens]]></source>
<year>1998</year>
<volume>7</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>681-5</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Friedlaender]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Fervenza]]></surname>
<given-names><![CDATA[FC]]></given-names>
</name>
<name>
<surname><![CDATA[Tsao]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rabkin]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The insulin-like growth factor-I axis in acute renal failure]]></article-title>
<source><![CDATA[Ren Fail]]></source>
<year>1998</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>343-8</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stefanidis]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Frank]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Maurin]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hemostasis activation markers in acute renal failure]]></article-title>
<source><![CDATA[Ren Fail]]></source>
<year>1998</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>147-55</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Libetta]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rampino]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Esposito]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fornoni]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Semeraro]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dal Canton]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stimulation of hepatocyte growth factor in human acute renal failure]]></article-title>
<source><![CDATA[Nephron]]></source>
<year>1998</year>
<volume>80</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>41-5</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mishra]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ma]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Prada]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mitsnefes]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zahedi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury]]></article-title>
<source><![CDATA[J Am Soc Nephrol]]></source>
<year>2003</year>
<volume>14</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>2534-43</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wen]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Parikh]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current concepts and advances in biomarkers of acute kidney injury]]></article-title>
<source><![CDATA[Crit Rev Clin Lab Sci]]></source>
<year>2021</year>
<volume>58</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>354-68</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xie]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tian]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Jin]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Xie]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biomarkers for the diagnosis of sepsis-associated acute kidney injury: systematic review and meta-analysis]]></article-title>
<source><![CDATA[Ann Palliat Med]]></source>
<year>2021</year>
<volume>10</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>4159-73</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ostermann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zarbock]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Goldstein]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kashani]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Macedo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Murugan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement]]></article-title>
<source><![CDATA[JAMA Netw Open]]></source>
<year>2020</year>
<volume>3</volume>
<numero>10</numero>
<issue>10</issue>
</nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buonafine]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez-Martinez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Jaisser]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases]]></article-title>
<source><![CDATA[]]></source>
<year>2018</year>
<volume>132</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>909-23</page-range></nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Update of NGAL in acute kidney injury]]></article-title>
<source><![CDATA[Curr Protein Pept Sci]]></source>
<year>2017</year>
<volume>18</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1211-7</page-range></nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shoaib]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mahmud]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
<name>
<surname><![CDATA[Safdar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early diagnosis of acute kidney injury by urinary neutrophil gelatinase associated lipocalin in adult critically ill patients]]></article-title>
<source><![CDATA[J Ayub Med Coll Abbottabad]]></source>
<year>2019</year>
<volume>31</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>12-5</page-range></nlm-citation>
</ref>
<ref id="B47">
<label>47</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mahadevaiah]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nidasale]]></surname>
<given-names><![CDATA[TMM]]></given-names>
</name>
<name>
<surname><![CDATA[Sashank]]></surname>
<given-names><![CDATA[YV]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnostic relevance of neutrophil gelatinase-associated lipocalin in early detection of acute kidney injury]]></article-title>
<source><![CDATA[Journal of Emergency Practice and Trauma]]></source>
<year>2021</year>
<volume>7</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>88-92</page-range></nlm-citation>
</ref>
<ref id="B48">
<label>48</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haase-Fielitz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Haase]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Devarajan]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status]]></article-title>
<source><![CDATA[Ann Clin Biochem]]></source>
<year>2014</year>
<volume>51</volume>
<numero>Pt 3</numero>
<issue>Pt 3</issue>
<page-range>335-51</page-range></nlm-citation>
</ref>
<ref id="B49">
<label>49</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ostermann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis of acute kidney injury: Kidney Disease Improving Global Outcomes criteria and beyond]]></article-title>
<source><![CDATA[Curr Opin Crit Care]]></source>
<year>2014</year>
<volume>20</volume>
<page-range>581-7</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
